Back
CRISPR Therapeutics AG Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
CRSP
CRISPR Therapeutics AG
Last Price:
47.89
Seasonality Move:
12.87%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.CRISPR Therapeutics AG Price Quote
$47.89
+0.01 (+3.46%)
(Updated: November 23, 2024 at 5:31 AM ET)
CRISPR Therapeutics AG Key Stats
Sell
45
CRISPR Therapeutics AG (CRSP)
is a Sell
Day range:
$45.85 - $48.00
52-week range:
$43.42 - $91.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.11%
Volume:
1.5M
Avg. volume:
1.6M
1-year change:
-32.08%
Market cap:
$4.1B
Revenue:
$370M
EPS:
$-2.8
How Much Does CRISPR Therapeutics AG Make?
Data Unavailable
Is CRISPR Therapeutics AG Growing As A Company?
Data Unavailable
CRISPR Therapeutics AG Stock Price Performance
-
Did CRISPR Therapeutics AG Stock Go Up Last Month?
CRISPR Therapeutics AG share price went down by -0.33% last month -
Did CRSP's Share Price Rise Over The Last Year?
CRSP share price fell by -32.08% over the past 1 year
What Is CRISPR Therapeutics AG 52-Week High & Low?
-
What Is CRISPR Therapeutics AG’s 52-Week High Share Price?
CRISPR Therapeutics AG has traded as high as $91.10 over the past 52 weeks -
What Is CRISPR Therapeutics AG’s 52-Week Low Share Price?
CRISPR Therapeutics AG has traded as low as $43.42 over the past 52 weeks
CRISPR Therapeutics AG Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy CRISPR Therapeutics AG?
-
How Much Debt Does CRISPR Therapeutics AG Have?
Total long term debt quarterly is $0 -
How Much Cash Does CRISPR Therapeutics AG Have?
Cash and short term investments quarterly total is $1.9B -
What Is CRISPR Therapeutics AG’s Book Value Per Share?
Book value per share is 22.73
Is CRISPR Therapeutics AG Cash Flow Positive?
-
What Is CRSP Cash Flow From Operations?
Cash flow from operations (TTM) is -$188.8M -
What Is CRISPR Therapeutics AG’s Cash Flow From Financing?
Cash flow from financing (TTM) is $354M -
What Is CRISPR Therapeutics AG’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$467.8M
CRISPR Therapeutics AG Return On Invested Capital
Data Unavailable
CRISPR Therapeutics AG Earnings Date & Stock Price
-
What Is CRISPR Therapeutics AG's Stock Price Today?
A single share of CRSP can be purchased today for 47.88 -
What Is CRISPR Therapeutics AG’s Stock Symbol?
CRISPR Therapeutics AG trades on the nasdaq under the ticker symbol: CRSP -
When Is CRISPR Therapeutics AG’s Next Earnings Date?
The next quarterly earnings date for CRISPR Therapeutics AG is scheduled on February 21, 2025 -
When Is CRSP's next ex-dividend date?
CRISPR Therapeutics AG's next ex-dividend date is November 24, 2024 -
How To Buy CRISPR Therapeutics AG Stock?
You can buy CRISPR Therapeutics AG shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
CRISPR Therapeutics AG Competitors
-
Who Are CRISPR Therapeutics AG's Competitors?
Below is a list of companies who compete with CRISPR Therapeutics AG or are related in some way:
CRISPR Therapeutics AG Dividend Yield
-
What Is CRSP Dividend Yield?
CRISPR Therapeutics AG’s dividend yield currently is 0% -
What Is CRISPR Therapeutics AG’s Payout Ratio?
CRISPR Therapeutics AG’s payout ratio is 0% -
When Did CRISPR Therapeutics AG Last Pay A Dividend?
The latest dividend pay date is November 24, 2024 -
What Is CRISPR Therapeutics AG’s Dividend Per Share?
CRISPR Therapeutics AG pays a dividend of $0.00 per share
CRISPR Therapeutics AG Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 28.11% |
| Revenue: | 0% | -91.56% |
Analyst Recommendations
| Buy Recommendations: | 11 |
|---|---|
| Hold Recommendations: | 11 |
| Sell Recommendations: | 2 |
| Price Target: | 81.54 |
| Upside from Last Price: | 70.3% |